期刊文献+

不同方案治疗多发性骨髓瘤46例疗效观察 被引量:1

下载PDF
导出
摘要 目的:探讨不同方案治疗多发性骨髓瘤的疗效。方法:采用沙利度胺联合不同的化疗方案治疗46例多发性骨髓瘤患者,并对这两种治疗方案进行疗效比较。结果:对两组患者的治疗疗效进行比较发现,虽然VAD组得总有效率高于MP组,但是差异无统计学意义(P>0.05),而VAD组的部分缓解率(69.57%)明显高于MP组的部分缓解率(39.13%),且差异具有统计学意义。结论:沙利度胺联合VAD方案治疗多发性骨髓瘤具有副作用少、耐受性好,方便迅速、价格低廉、疗效显著,值得临床推广使用。
作者 龚雪莲 张梅
出处 《航空航天医药》 2009年第3期72-73,共2页 Aerospace Medicine
  • 相关文献

参考文献3

二级参考文献16

  • 1[3]Hideshima T,Chauhan D,Shima Y,et al.Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to onventional therapy.Blood,2000,96(9):2943-2950.
  • 2[4]Barlogie B,Desikan R,Eddlemon P,et al.Extended survival in advanced and refractory mulitiple myeloma after single-agent thalidomide:identification of prognostic factors in a phase 2 study of 169 patients.Blood,2001,98(2):492-494.
  • 3[5]Davies FE,Raje N,Hideshima T,et al.Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.Blood,2001,98(1):210-216.
  • 4Myeloma Trialists' Collaborative Group.Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma:an overview of 6633 patients from 27 randomized trials[J].J Clin Oncol,1998,16(12):3832.
  • 5Singhal S,Mehta J,Desikan R,et al.Antitumor activity of thalidomide in refractory multiple myeloma[J].N Eng J Med,1999,341:1565.
  • 6Tosi P,Ronconi S,Zamagni E,et al.Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation[J].Haematologica,2001,86:409.
  • 7Celgene.Program and abstracts of the Ⅷ international myeloma workshop[M].Canada,2001:4.
  • 8Garcia-Sanz R,Gonzalez-Fraile MI,Sierra M,et al.The combination of thalidomide cyclophosphamide and dexamethasone(ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma[J].Hematol J,2002,3(1):43.
  • 9Palumbo A,Bringhen S,Caravita T,et al.Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma:randomised controlled trial[J].Lancet,2006,367(9513):825.
  • 10Davies FE,Raje N,Hideshma T,et al.Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma a[J].Blood,2001,98(1):210.

共引文献8

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部